Phase 4 Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 75 years old, either male or female (who are not pregnant)
- People who have been diagnosed with an unruptured brain aneurysm (a bulge in a blood vessel in the brain that has not burst), confirmed by a specialised brain scan (such as CTA, MRA, or DSA)
- People whose aneurysm measures between 3mm and 25mm at its widest point
- People who understand what the procedure involves and have agreed to take part in writing
- People whose doctor has determined they need a flow diverter device placed in the blood vessel, with or without additional coil treatment, to manage their aneurysm
- People who are willing to return to the trial site for follow-up visits as required by the study
Who may not be able to join:
- People who have a medical reason to avoid atorvastatin (a cholesterol-lowering medicine), or who have a known allergy to it
- People who are pregnant or breastfeeding
- People who have other blood vessel conditions, such as coronary artery disease, a large artery aneurysm in the abdomen, narrowing of brain arteries, abnormal blood vessel connections in the brain, or certain other vascular diseases
- People who have already been taking a statin medication for 30 days or more, or who have a medical reason to be on atorvastatin according to Chinese lipid management guidelines
- People whose aneurysm has already burst, or whose aneurysm has already been treated with surgery or a procedure inside the blood vessel
- People currently taking certain medications that can interact with atorvastatin, including some antibiotics, antifungals, anti-rejection drugs, other cholesterol-lowering medications, certain stomach medicines, and others (confirm with trial site for the full list)
- People who have more than one brain aneurysm and need treatment for two or more of them within a one-year period
- People whose aneurysm is not the standard rounded (saccular) shape — for example, those with a dissecting, fusiform, false, or infected aneurysm
- People who cannot take blood-thinning or anti-clotting medications, who have an allergy or medical reason to avoid the materials used in the flow diverter device, or who have had a life-threatening reaction to contrast dye used in scans
- People whose doctors have determined they cannot safely undergo general anaesthesia
- People who are unwilling to attend follow-up visits or who are unlikely to follow the study plan
- People whose life expectancy is less than 3 years
- People with a severe neurological disability that means they cannot live independently (as measured by a standard disability scale — confirm with trial site)
- People who are currently enrolled in another clinical trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Chuanzhi Duan, MD, Southern Medical University, China
Phone: 02062782757
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy endopoint
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.